DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lunesta (Eszopiclone) - Adverse Event Reports - Life Threatening Events

 



Index of reports > Cases resulting in life threatening events (18)

     Infection (5)Catatonia (5)Convulsion (5)Hypertensive Crisis (5)Feeling Abnormal (5)Confusional State (4)Encephalitis (4)Meningitis Viral (4)Speech Disorder (4)Depressed Level of Consciousness (4)

Below is the selection of adverse event reports related to Lunesta (Eszopiclone) that includes cases resulting in life threatening events.

Adverse event in male receiving Lunesta (Eszopiclone)

Reported by a physician from United States on 2007-10-26

Patient: male

Adverse reactions / side effects: Multiple Drug Overdose, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Lunesta (Eszopiclone)



Adverse event in receiving Lunesta (Eszopiclone)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-24

Patient:

Adverse reactions / side effects: Multiple Drug Overdose

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Diphenhydramine HCL
    End date: 2006-11-05

Lunesta
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2006-11-05

Seroquel
    Administration route: Oral
    End date: 2006-11-05



Adverse event in receiving Lunesta (Eszopiclone)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-31

Patient:

Adverse reactions / side effects: Multiple Drug Overdose

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Diphenhydramine HCL
    End date: 2006-11-05

Lunesta
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2006-11-05

Seroquel
    Administration route: Oral
    End date: 2006-11-05



Adverse event in 45 year old female receiving Lunesta (Eszopiclone)

Reported by a physician from United States on 2007-07-23

Patient: 45 year old female

Adverse reactions / side effects: Multiple Drug Overdose

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Diphenhydramine HCL
    End date: 2006-11-05

Lunesta
    Dosage: oral
    Administration route: Oral
    Start date: 2006-11-01
    End date: 2006-11-05

Seroquel
    End date: 2006-11-05



Adverse event in receiving Lunesta (Eszopiclone)

Reported by a physician from United States on 2007-07-18

Patient:

Adverse reactions / side effects: Overdose

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Lunesta (Eszopiclone)



Adverse event in 71 year old male receiving Lunesta (Eszopiclone)

Reported by a consumer/non-health professional from United States on 2007-07-06

Patient: 71 year old male, weighing 74.8 kg (164.7 pounds)

Adverse reactions / side effects: Agitation, Cellulitis, Drug Effect Decreased, Sleep Disorder, Depression, Pharmaceutical Product Complaint, Asthenia, Suicidal Ideation

Adverse event resulted in: life threatening event

Suspect drug(s):
Lunesta (Eszopiclone)



Adverse event in 76 year old female receiving Lunesta (Eszopiclone)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-03

Patient: 76 year old female

Adverse reactions / side effects: Confusional State, General Physical Health Deterioration, Encephalitis, Catatonia, Disorientation, Meningitis Viral, Convulsion, Hypertensive Crisis, Speech Disorder, Depressed Level of Consciousness, Feeling Abnormal, Infection

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aricept
    Start date: 2007-06-01

Lunesta
    Start date: 2007-06-07

Namenda
    Start date: 2007-06-01

Other drugs received by patient: Ultram; Lortab (Hydrocodone); Naprosyn; Klonopin



Adverse event in 76 year old female receiving Lunesta (Eszopiclone)

Reported by a consumer/non-health professional from United States on 2007-06-27

Patient: 76 year old female

Adverse reactions / side effects: Confusional State, Dysphagia, Encephalitis, Catatonia, Meningitis Viral, Disorientation, Hypertensive Crisis, Convulsion, Speech Disorder, CSF Protein Increased, Depressed Level of Consciousness, Feeling Abnormal, Myocardial Infarction, Infection

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aricept
    Dosage: 1 in 1 d, oral
    Administration route: Oral
    Indication: Delusion
    Start date: 2007-06-01

Lunesta
    Dosage: oral
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-06-06

Namenda
    Dosage: oral
    Administration route: Oral
    Indication: Delusion
    Start date: 2007-06-01

Other drugs received by patient: Ultram; Lortab; Naprosyn; Klonopin



Adverse event in 76 year old female receiving Lunesta (Eszopiclone)

Reported by a consumer/non-health professional from United States on 2007-06-27

Patient: 76 year old female

Adverse reactions / side effects: Confusional State, General Physical Health Deterioration, Encephalitis, Catatonia, Disorientation, Meningitis Viral, Convulsion, Hypertensive Crisis, Speech Disorder, CSF Protein Increased, Depressed Level of Consciousness, Feeling Abnormal, Infection

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aricept
    Dosage: 1 in 1 d, oral
    Administration route: Oral
    Indication: Delusion
    Start date: 2007-06-01

Lunesta
    Dosage: oral
    Administration route: Oral
    Start date: 2007-06-06

Namenda
    Dosage: oral
    Administration route: Oral
    Indication: Delusion
    Start date: 2007-06-01

Other drugs received by patient: Ultram; Lortab; Naprosyn (Naprosyn); Klonopin



Adverse event in 76 year old female receiving Lunesta (Eszopiclone)

Reported by a consumer/non-health professional from United States on 2007-06-26

Patient: 76 year old female

Adverse reactions / side effects: Catatonia, Encephalitis, General Physical Health Deterioration, Meningitis Viral, Hypertensive Crisis, Convulsion, Hyperventilation, Panic Attack, Oedema Peripheral, Feeling Abnormal, Myocardial Infarction, Infection

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aricept
    Dosage: oral
    Administration route: Oral
    Indication: Decubitus Ulcer
    Start date: 2007-06-01

Aricept
    Dosage: oral
    Administration route: Oral
    Indication: Delusion
    Start date: 2007-06-01

Aricept
    Dosage: oral
    Administration route: Oral
    Indication: Pain
    Start date: 2007-06-01

Lunesta
    Dosage: oral
    Administration route: Oral
    Indication: Confusional State
    Start date: 2007-06-06

Namenda
    Dosage: oral
    Administration route: Oral
    Indication: Confusional State
    Start date: 2007-06-01

Other drugs received by patient: Ultram; Lortab; Naprosyn; Klonopin



Adverse event in 76 year old female receiving Lunesta (Eszopiclone)

Reported by a consumer/non-health professional from United States on 2007-06-18

Patient: 76 year old female

Adverse reactions / side effects: Confusional State, General Physical Health Deterioration, Catatonia, Disorientation, Convulsion, Hypertensive Crisis, Speech Disorder, Depressed Level of Consciousness, Feeling Abnormal, Myocardial Infarction, Infection

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Aricept
    Dosage: oral
    Administration route: Oral
    Indication: Confusional State
    Start date: 2007-06-01

Aricept
    Dosage: oral
    Administration route: Oral
    Indication: Delusion
    Start date: 2007-06-01

Lunesta
    Dosage: oral
    Administration route: Oral
    Start date: 2007-06-06

Namenda
    Dosage: oral
    Administration route: Oral
    Indication: Confusional State
    Start date: 2007-06-01

Namenda
    Dosage: oral
    Administration route: Oral
    Indication: Delusion
    Start date: 2007-06-01

Other drugs received by patient: Ultram; Lortab; Naprosyn; Klonopin



Adverse event in 67 year old female receiving Lunesta (Eszopiclone)

Reported by a physician from United States on 2007-06-12

Patient: 67 year old female

Adverse reactions / side effects: Incorrect Dose Administered

Adverse event resulted in: life threatening event

Suspect drug(s):
Lunesta
    Dosage: 279 mg; oral
    Administration route: Oral

Xanax
    Dosage: 20 mg



Adverse event in 54 year old male receiving Lunesta (Eszopiclone)

Reported by a consumer/non-health professional from United States on 2007-04-17

Patient: 54 year old male, weighing 83.9 kg (184.6 pounds)

Adverse reactions / side effects: Agitation, Irritability, Insomnia, Depressed Mood, Suicidal Ideation

Adverse event resulted in: life threatening event

Suspect drug(s):
Lamictal
    Indication: Bipolar I Disorder

Lunesta
    Indication: Sleep Disorder
    Start date: 2007-03-18
    End date: 2007-03-29

Other drugs received by patient: Actos; Metformin HCL; Cozaar; Lamictal; Androgel



Adverse event in 44 year old male receiving Lunesta (Eszopiclone)

Reported by a consumer/non-health professional from United States on 2007-03-28

Patient: 44 year old male, weighing 63.5 kg (139.7 pounds)

Adverse reactions / side effects: Emotional Distress, Abnormal Behaviour, Amnesia

Adverse event resulted in: life threatening event

Suspect drug(s):
Lunesta
    Dosage: 3 mg 1 / night po
    Administration route: Oral
    Indication: Anxiety
    Start date: 2007-03-27
    End date: 2007-03-27

Lunesta
    Dosage: 3 mg 1 / night po
    Administration route: Oral
    Indication: Poor Quality Sleep
    Start date: 2007-03-27
    End date: 2007-03-27



Adverse event in 26 year old female receiving Lunesta (Eszopiclone)

Reported by a physician from United States on 2007-03-21

Patient: 26 year old female, weighing 68.0 kg (149.7 pounds)

Adverse reactions / side effects: Respiratory Arrest

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Kadian
    Dosage: 80 mg; bid; oral
    Administration route: Oral
    Indication: Neck Pain
    Start date: 2007-02-21
    End date: 2007-02-23

Lunesta
    Dosage: 2 mg;hs;oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-02-01

Other drugs received by patient: Norco



Adverse event in 53 year old male receiving Lunesta (Eszopiclone)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-20

Patient: 53 year old male, weighing 95.3 kg (209.6 pounds)

Adverse reactions / side effects: Abnormal Sleep-Related Event, Post Concussion Syndrome, Neck Injury, Somnolence, Amnesia, Loss of Consciousness, Road Traffic Accident, Back Injury

Adverse event resulted in: life threatening event

Suspect drug(s):
Lunesta (Eszopiclone)



Adverse event in 56 year old male receiving Lunesta (Eszopiclone)

Reported by a physician from United States on 2007-03-09

Patient: 56 year old male, weighing 64.0 kg (140.7 pounds)

Adverse reactions / side effects: Hypoventilation, Drug Screen Positive, Troponin Increased, Computerised Tomogram Abnormal, Loss of Consciousness, Respiratory Rate Decreased, Alcohol USE, Lethargy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Lunesta
    Dosage: 3 mg;hs; oral; 6 mg; 1x; oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-02-05
    End date: 2007-02-01

Lunesta
    Dosage: 3 mg;hs; oral; 6 mg; 1x; oral
    Administration route: Oral
    Indication: Insomnia
    End date: 2007-02-01

Other drugs received by patient: Cymbalta; Wellbutrin; Provigil; Aspirin



Adverse event in 56 year old male receiving Lunesta (Eszopiclone)

Reported by a physician from United States on 2007-02-28

Patient: 56 year old male

Adverse reactions / side effects: Respiratory Rate Decreased, Inappropriate Schedule of Drug Administration, Hypoventilation, Lethargy, Loss of Consciousness

Adverse event resulted in: life threatening event

Suspect drug(s):
Lunesta (Eszopiclone)

Other drugs received by patient: Cymbalta; Wellbutrin; Provigil

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009